What is the translation of " RELEVANT DIFFERENCES " in Danish?

• relevante forskelle
• relevant forskel

Examples of using Relevant differences in English and their translations into Danish

No relevant differences in pharmacokinetics have been observed.
Der er ikke observeret relevant forskel i farmakokinetikken.

In a study in healthy Japanese and Caucasian subjects no clinically relevant differences in pharmacokinetic parameters were observed.
Der er ikke set nogen kliniske relevante forskelle i de farmakokinetiske parametre i et studie med raske japanere og kaukasiere.

No relevant differences in the safety profile were seen in this patient population.
Der blev ikke observeret relevante forskelle i sikkerhedsprofilen i denne patientpopulation.

The analysis of the impact of NSCLC histology on overall survival demonstrated clinically relevant differences in survival according to histology, see table below.
Analysen af indvirkningen på NSCLC- histologien for samlet overlevelse viste klinisk relevante forskelle i overlevelse baseret på histologi, se nedenstående tabel.

No clinically relevant differences in aprepitant pharmacokinetics is expected due to age and gender.
Der forventes ingen klinisk relevante forskelle i aprepitants farmakokinetik på grund af alder og køn.

Gender There were no clinically relevant differences in the clearance of tigecycline between men and women.
Køn Der var ingen klinisk relevante forskelle i tigecyclins clearance hos mænd og kvinder.

No relevant differences in exposure were apparent when data from the Caucasian population was compared with either the Japanese or Black population.
Der var tilsyneladende ingen relevante forskelle i eksposition, når data fra den hvide population blev sammenlignet med enten den japanske eller sorte population.

There are no clinically relevant differences in pharmacokinetics between Caucasian and Asian subjects.
Der er ingen klinisk relevante forskelle i farmakokinetikken mellem kaukasiske og asiatiske patienter.

No clinically relevant differences in the total number of adverse events were found between canagliflozin and comparator drugs.
Der var ingen klinisk relevant forskel i det samlede antal bivirkninger mellem canagliflozin og sammenligningspræparater.

There are no clinically relevant differences due to age in the pharmacokinetics of cinacalcet.
Der var ingen klinisk relevante forskelle forårsaget af alder i de farmakokinetiske egenskaber for cinacalcet.

There were no relevant differences between Valtropin and the reference product with regard to height velocity and height velocity SDS.
Der var ingen relevante forskelle imellem Valtropin og referenceproduktet, hvad angår væksthastighed og væksthastighedens SDS.

There are no clinically relevant differences between genders in pharmacokinetic properties of insulin detemir.
Der var ingen klinisk relevant forskel mellem kønnene i de farmakokinetiske egenskaber for insulin detemir.

No clinically relevant differences in the pharmacokinetics of vildagliptin were observed between male and female healthy subjects within a wide range of age and body mass index BMI.
Der blev ikke observeret nogen klinisk relevante forskelle i vildagliptins farmakokinetik hos mandlige og kvindelige forsøgspersoner inden for et bredt interval af alder og BMI.

There were no clinically relevant differences in pharmacokinetics and pharmacodynamics between male and female patients.
Der var ingen klinisk relevante forskelle mellem mænd og kvinder, hvad angår farmakokinetik og farmakodynamik.

No clinically relevant differences were seen in the pharmacokinetics of repaglinide, when repaglinide was administered 0, 15 or 30 minutes before a meal or in fasting state.
Der blev ikke observeret klinisk relevante forskelle i de farmakokinetiske parametre, når repaglinid blev givet 0, 15, 30 minutter før et måltid eller i forbindelse med fastende tilstand.

There were no clinically relevant differences observed for the safety profile of ALIMTA within the histology subgroups.
Der blev ikke set nogen klinisk relevante forskelle i ALIMTAs sikkerhedsprofil inden for de histologiske undergrupper.

No clinically relevant differences in the pharmacokinetics of insulin detemir are expected between healthy subjects and subjects with renal or hepatic impairment, based on the studies performed.
På baggrund af undersøgelserne forventes der ingen kliniske relevante forskelle i de farmakokinetiske egenskaber af insulin detemir mellem sunde personer og personer med nedsat nyre- eller leverfunktion.

There were no clinically relevant differences observed for the safety profile of ALIMTA plus cisplatin within the histology subgroups.
Der blev ikke set klinisk relevante forskelle i sikkerhedsprofilen for ALIMTA plus cisplatin inden for de histologiske undergrupper.

There are no clinically relevant differences in serum insulin or glucose levels after abdominal, deltoid or thigh administration of Lantus.
Der er ikke set klinisk relevante forskelle i serum- insulin og glukoseniveau efter indgift af Lantus på abdomen, lår eller overarm.

There were no clinically relevant differences in the safety population of the elderly subjects who received oseltamivir or placebo compared with the adult population aged up to 65 years.
Der var ingen klinisk relevante forskelle i sikkerhedspopulationen af de ældre forsøgspersoner, som fik oseltamivir eller placebo, sammenlignet med voksenpopulationen i alderen op til 65 år.

Characteristics in patients Gender No clinically relevant differences in the pharmacokinetics of vildagliptin were observed between male and female healthy subjects within a wide range of age and body mass index BMI.
Køn Der blev ikke observeret nogen klinisk relevante forskelle i vildagliptins farmakokinetik hos mandlige og kvindelige forsøgspersoner inden for et bredt interval af alder og BMI.

No relevant difference between Caucasian, Asian and Black subjects has been observed.
Der er ikke observeret relevante forskelle mellem hvide, asiater og sorte forsøgspersoner.

There was no clinically relevant difference in pharmacokinetic properties.
Der var ingen klinisk relevant forskel i de farmakokinetiske egenskaber.

Overall, no clinically relevant difference between genders was observed.
Generelt blev der ikke observeret nogen klinisk relevant forskel mellem de to køn.

It is a relevant difference.
Det er en relevant forskel.

No clinically relevant difference in ulcer prevention between the 15 and 30 mg dose of lansoprazole could be demonstrated.
Ingen klinisk relevant forskel i forebyggelse af ulcera kunne påvises mellem dosen på 15 mg og 30 mg lansoprazol.

The relatively limited data available so far provide no evidence of a clinically relevant difference in the pharmacokinetics of males and females.
De relativt begrænsede data, som foreligger indtil nu, frembyder ikke bevis for en klinisk relevant forskel i farmakokinetikken hos mænd og kvinder.

Clinically relevant difference in lacosamide exposure was observed comparing its pharmacokinetics in extensive metabolisers(EMs, with a functional CYP2C19) and poor metabolisers PMs, lacking a functional CYP2C19.
Der blev imidlertid ikke observeret nogen klinisk relevant forskel i eksponeringen for lacosamid, når man sammenlignede med farmakokinetikken hos patienter med hurtig metabolisering(med et funktionelt CYP2C19 enzym) og patienter med langsom metabolisering uden et funktionelt CYP2C19 enzym.

Compared to the insulin analogues glargin and detemir no clinically relevant difference in the effect on HbA1c after 26 or 52 weeks of treatment has been found. However, the glucose lowering effect is maintained for a longer period of time with degludec and the day-to-day variation is less compared to glargin.
Sammenlignet med insulinanalogerne glargin og detemir er der ikke fundet klinisk relevant forskel i effekten på HbA1c efter 26 eller 52 ugers behandling, men den glukosesænkende effekt fastholdes over længere tid med degludec, og der er mindre dag-til-dag variation sammenlignet med glargin.